Drug Discovery World

JANUARY 19, 2023

billion by 2030 (BioSpace, 11 August 2022). Plasmid DNA: a critical reagent pDNA is the starting material for the development of many cell and gene therapy products, irrespective of the mode of action. This rapid emergence of cell and gene therapies has fuelled demand for plasmids and has created a manufacturing ‘bottleneck’.

DNA 130

DNA Therapies Assay Development Production 130

Drug Discovery World

APRIL 25, 2024

According to Grand View Research, the global cell line development market was valued at $4.81 billion in 2022, a figure that is expected to grow at a compound annual growth rate (CAGR) of 9.81% from 2023 to 2030 1. Looking ahead, it’s clear that the role of technology is playing a big role in advancing cell lines.

Vaccine 147

Vaccine Production Pharmaceuticals Therapies 147

Drug Discovery World

FEBRUARY 15, 2023

Another revolutionary discovery was the elucidation of the role of IL2 in T cell growth and activation in the 1970s, that later paved the way for the treatment of patients with metastatic melanoma and renal cancer. Over 250 clinical trials are currently in progress, and novel immuno-oncological treatments are already proving to be successful.

Research 130

Research Therapies Immune Response Clinical Trials 130